Current role
Biotechnology · Healthcare
CEO, Board Member
2024-10-04–present
Nicholas Saccomano
Board Member
OnKure Therapeutics, Inc. (OKUR)Equibles does not estimate personal net worth.
Get an email with a short summary when OnKure Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get OKUR alertsAbout Nicholas Saccomano
Nicholas Saccomano is recorded as CEO and Board Member at OnKure Therapeutics, Inc. (OKUR) since October 4, 2024. OnKure Therapeutics, Inc. reported in an 8-K filed October 8, 2024 that Nicholas Saccomano was appointed Class I director. OnKure Therapeutics, Inc. reported in an 8-K filed October 8, 2024 that Nicholas Saccomano was appointed President and Chief Executive Officer (Principal Executive Officer), effective October 4, 2024. OnKure Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at OnKure Therapeutics, Inc. includes Nicholas A. Saccomano (CEO and Board Member), Nicholas A. Saccomano, Ph.D. (CEO), Andrew Phillips (Chairman and Board Member) and 7 others.
“Effective as of the Effective Time, Nicholas Saccomano and Isaac Manke were appointed as Class I directors, R. Michael Carruthers, Valerie M. Jansen and Edward T. Mathers were appointed as Class II directors and Andrew Phillips and Michael Grey were appointed as Class III directors.”
“On October 4, 2024, the following individuals were appointed to serve as executive officers of the Combined Company:”
Affiliation history
-
Current
2024-10-04–present
-
Current
2024-10-04–present
Company network
Leadership on record at OnKure Therapeutics, Inc.
- Nicholas A. Saccomano CEO, Board Member
- Nicholas A. Saccomano, Ph.D. CEO
- Andrew Phillips Chairman, Board Member
- Jason Leverone CFO
- Jennifer P. Lam CFO
- Michael P. Cruse COO
- Andrew Philips, Ph.D. Board Member
- Continuing Directors Board Member
- Dr. Liam Ratcliffe Board Member
- Edward T. Mathers Board Member